UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 42.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 155,010 shares of the company's stock after purchasing an additional 46,395 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.10% of Integral Ad Science worth $1,618,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of IAS. Alyeska Investment Group L.P. acquired a new stake in shares of Integral Ad Science during the fourth quarter worth about $41,543,000. Dimensional Fund Advisors LP raised its position in Integral Ad Science by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock worth $39,567,000 after buying an additional 580,323 shares during the last quarter. Clearline Capital LP purchased a new position in Integral Ad Science during the 4th quarter worth approximately $3,949,000. Invenomic Capital Management LP lifted its stake in Integral Ad Science by 52.9% during the 4th quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock valued at $9,344,000 after acquiring an additional 309,752 shares during the period. Finally, Ararat Capital Management LP boosted its holdings in shares of Integral Ad Science by 13.4% in the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock valued at $23,823,000 after acquiring an additional 269,346 shares during the last quarter. Hedge funds and other institutional investors own 95.78% of the company's stock.
Integral Ad Science Stock Down 0.2%
Integral Ad Science stock opened at $8.22 on Monday. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71. The stock has a market capitalization of $1.36 billion, a PE ratio of 41.10, a price-to-earnings-growth ratio of 1.06 and a beta of 1.59. The business has a 50 day simple moving average of $7.43 and a 200-day simple moving average of $9.23. Integral Ad Science Holding Corp. has a 12 month low of $6.26 and a 12 month high of $13.62.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.03 by $0.02. The company had revenue of $134.07 million during the quarter, compared to analyst estimates of $129.20 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. On average, analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.
Analyst Ratings Changes
IAS has been the subject of a number of research reports. Truist Financial boosted their target price on shares of Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a research report on Monday, March 3rd. Benchmark reiterated a "hold" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Stifel Nicolaus lowered their target price on Integral Ad Science from $15.00 to $13.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Morgan Stanley reduced their price target on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Finally, Oppenheimer reissued an "outperform" rating on shares of Integral Ad Science in a report on Friday, February 28th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $13.55.
Read Our Latest Stock Report on Integral Ad Science
Insider Buying and Selling
In related news, CEO Lisa Utzschneider sold 8,367 shares of the business's stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $7.37, for a total transaction of $61,664.79. Following the completion of the sale, the chief executive officer now directly owns 349,574 shares in the company, valued at approximately $2,576,360.38. The trade was a 2.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders sold a total of 86,222 shares of company stock worth $636,252 in the last 90 days. Insiders own 2.00% of the company's stock.
Integral Ad Science Profile
(
Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Stories
Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.